Breast Neoplasms: all 12,820 studies
Page 18 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Feasibility Study to Evaluate the Use of Patient Reported Complications After Digital ConsentRecruitingNCT06351865
- A Patient Navigation Program for Addressing Disparities in Breast Cancer CareRecruitingNCT06350500Not applicable
- New Digital Person-based Care Model in Patients With HER2-negative Advanced Breast CancerNot yet recruitingNCT06348654
- Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After SurgeryRecruitingNCT06348134Phase 2
- Study of Sexual Quality of Life in Women With Breast Cancer Who Had Multidisciplinary Management With Photobiomodulation for Genitourinary Syndrome of the MenopauseRecruitingNCT06347926Not applicable
- Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T CellsRecruitingNCT06347068Phase 1
- Breast Cancer & Antiestrogenic Therapy & BrainNot yet recruitingNCT06346457
- FAST-FORWARD vs HAI5RecruitingNCT06345534Not applicable
- A Qualitative Study on Treatment Adherence in Patients With Metastatic Breast CancerRecruitingNCT06343181
- NOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC) Patients: TONIC-3 TrialRecruitingNCT06342037Phase 2
- Efficacy and Safety of Dalpiciclib With Endocrine Therapy as Adjuvant Treatment in HR+/ HER2- Early Breast CancerRecruitingNCT06341894Phase 2
- Potential Protective Role of SGLT-2 Inhibitors for Chemotherapy-induced CardiotoxicityRecruitingNCT06341842Phase 2
- Chemotherapy Omission in ER+/HER2- Breast Cancer With 1-3 Positive Lymph Nodes Receiving Extended Adjuvant AbemaciclibRecruitingNCT06341621Phase 3
- A Retrospective Real-world Study of Abemaciclib in HR+ Breast CancerNot yet recruitingNCT06341283
- NT-proBNP to Assess Trastuzumab-induced CardiotoxicityRecruitingNCT06340516Not applicable
- Italian Validation of a Tool for Assessing Sexual Function After Breast Cancer, FSFI-BCRecruitingNCT06340386
- SHR-A1811 Alone or in Combination With Adebrelimab as Neoadjuvant Treatment in HR Positive/HER2 Low Breast CancerRecruitingNCT06340230Phase 2
- A Real-world Efficacy and Safety Study of Amlotinib for HER2-negative Advanced Breast CancerRecruitingNCT06340165
- ICG vs Blue Patent for TAD in cN1 Breast Carcinoma After Neoadjuvant ChemotherapyRecruitingNCT06339658
- A Multicenter Clinical Study of Apatinib Mesylate Combined With Doctor's Choice for Advanced Breast CancerNot yet recruitingNCT06339281Phase 2
- Palbociclib in Metastatic Breast Cancer: Gene Polymorphism-based Study in Egyptian Patients.Not yet recruitingNCT06338644
- TCM Therapy Program Impact on Breast Cancer Patients' Vital EnergyRecruitingNCT06337214Not applicable
- A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer DiagnosisRecruitingNCT06336928
- 18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer.RecruitingNCT06335069Phase 2
- Whole Genome Sequencing in Breast CancerRecruitingNCT06334471
- CARDIOCARE Prospective Clinical StudyRecruitingNCT06334445
- PrefeRences And ChemoTherapy In Breast Cancer patiEntsRecruitingNCT06332976
- Anlotinib With Trastuzumab Deruxtecan for Previously Treated HER2-Low Advanced Breast CancerRecruitingNCT06331169Phase 1
- Brain Metastasis Development Mechanism in BCBM PatientsRecruitingNCT06330870Not applicable
- The Resistance Mechanism of Trastuzumab Deruxtexan in HER2 Positive Breast Cancer Patients.RecruitingNCT06330012Not applicable
- Reoperative Sentinel Lymph Node Biopsy in Patients With Recurrent Ipsilateral Breast CancerRecruitingNCT06329089
- HCQ+ADC vs ADC in the Treatment of Advanced Breast CancerRecruitingNCT06328387Phase 1/2
- Psychosexuological Interventions to Support Sexual Function in Breast Cancer PatientsRecruitingNCT06327607
- A Study Evaluating the Feasibility and Compliance of Manual Lymphatic Drainage Comparing Indocyanine-Green (ICG) Guided vs. Traditional Guided in Patients Undergoing Axillary Node Dissection for the Treatment of Breast CancerRecruitingNCT06327490Phase 2
- Effect of Complex Decongestive Therapy, Cryotherapy and Kinesio Taping in Patients With Post-mastectomy Lymphedema: A Randomized Control TrialRecruitingNCT06327438Not applicable
- Who and Why do Patients Report Lymphedema After Breast Cancer Treatment Without an Objective Measurable SwellingRecruitingNCT06324721Not applicable
- Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has SpreadRecruitingNCT06324357Phase 1/2
- Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast CancerRecruitingNCT06324240Phase 1
- Lymphedema Evaluation After Adjuvant Hypofractionated Radiotherapy for 1-2 Macrometastatic Sentinel Lymph NodesRecruitingNCT06321653
- Minimal Access Versus Conventional Latissimus Dorsi Flap Harvest for Breast ReconstructionRecruitingNCT06319157Not applicable
- The Intestinal Microbiome in Triple Negative Breast Cancer Treated with ImmunotherapyRecruitingNCT06318507
- Breast Cancer Subtype Characterization Through Patient's Derived Organoids.RecruitingNCT06315868
- A Phase Ⅲ Study of Hemay022 in Combination With AI In Advanced Breast CancerRecruitingNCT06313983Phase 3
- AMH Predicts Postchemotherapy Menopause in Premenopausal Breast Cancer PatientsNot yet recruitingNCT06313476
- Study Of Capecitabine Combined With Camrelizumab For Non-pCR TNBC With TLS After Neoadjuvant ChemoterapyRecruitingNCT06313463Phase 3
- DP303c Versus Trastuzumab Emtansine in in Patients With HER2-positive Advanced Breast CancerRecruitingNCT06313086Phase 3
- Neoadjuvant Radiotherapy for Breast CancerRecruitingNCT06313073Not applicable
- A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)RecruitingNCT06312176Phase 3
- Contrast-Enhanced Spectral Mammography (CESM)RecruitingNCT06311695Phase 2
- Percent Weight Change in the Medical Supplement Group of Early Breast CancerRecruitingNCT06311357Not applicable
- TRUST-ACE - Anticancer-treatment Cardiotoxicity Identification by EchocardiographyRecruitingNCT06310330Not applicable
- Decision Impact Study of PreciseDx BreastNot yet recruitingNCT06309615
- Prehabilitation With Resistance-exercise Training for Breast Cancer Neoadjuvant TherapyRecruitingNCT06309290Not applicable
- Eribulin Combined With Sintilimab as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Breast Cancer:A Multicenter, Single-arm,Phase II Clinical TrialNot yet recruitingNCT06308939Phase 2
- Effectiveness of an eHealth Self-management Support Program for Persistent Pain After Breast Cancer TreatmentRecruitingNCT06308029Not applicable
- Community Services Navigation to Advance Health Equity in Breast Cancer ScreeningRecruitingNCT06305312Not applicable
- CardioPROTECTion with Dapagliflozin in Breast Cancer Patients Treated with AnthrAcycline - PROTECTAA TRIALRecruitingNCT06304857Phase 3
- Percutaneous Cryoablation of Low-risk Early Breast CancerRecruitingNCT06300125
- Stereotactic Radiation Therapy for HE2-positive Oligometastatic Breast CancerRecruitingNCT06299852Not applicable
- Contrast-enhanced Spectral Mammography (CESM) Early Quantitative Evaluation of Tumoral Response and Pathologic Complete Response Prediction for Localized Breast Cancer Treated by Neoadjuvant ChemotherapyRecruitingNCT06299202Not applicable
- Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon SatisfactionRecruitingNCT06294574Not applicable
- Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid TumorsRecruitingNCT06293898Phase 1
- Microwave Ablation in the Treatment of Early-stage Unifocal Invasive Breast CancerRecruitingNCT06288620Not applicable
- AI-Assisted System for Accurate Diagnosis and Prognosis of Breast Phyllodes TumorsRecruitingNCT06286267
- Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer ChemotherapyRecruitingNCT06282796
- Treatment Pleural Carcinosis of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin AdministrationRecruitingNCT06281860Phase 1
- Vabb After Neoadjuvant Therapy to Avoid Surgery-pCR to Avoid Breast SurgeryRecruitingNCT06281210Not applicable
- Stress-Reducing Intervention in Patients With Colorectal and Breast CancerRecruitingNCT06281145Not applicable
- The Effect of Mobile Health Application on Posttraumatic Growth in Women Diagnosed With Breast CancerNot yet recruitingNCT06279806Not applicable
- Disitamab Vedotin + Pyrotinib Versus THP in the First-line Treatment for HER2+ Advanced Breast Cancer Clinical TrialRecruitingNCT06278870Phase 3
- Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast CancerRecruitingNCT06276868Phase 2
- Intraoperative Imaging of Lymph NodesRecruitingNCT06276439
- Physical Exercise Benefits for Cancer PatientsRecruitingNCT06275321Not applicable
- Optimizing Surgical Decisions in Young Adults With Breast CancerRecruitingNCT06275126Not applicable
- Visually Impaired Women Model-based Cancer Education and Breast Self-examinationNot yet recruitingNCT06274762Not applicable
- A Study to Investigate Mechanisms of Resistance to Breast Cancer TherapiesRecruitingNCT06274515Phase 4
- Chemosensitivity During Phases of the Menstrual Cycle in Breast Cancer PatientsRecruitingNCT06273800Not applicable
- Tolerability and Efficacy of Adjuvant T-DM1 in Patients with HER2 Positive Breast Cancer After Incomplete Pathological Response to Neoadjuvant Chemotherapy Including Anti-HER2 Agents.RecruitingNCT06272799
- Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced NeuropathyRecruitingNCT06268665Phase 2
- Patient Derived Organoid-guided Personalized Treatment Versus Treatment of Physician's Choice in Breast CancerRecruitingNCT06268652Phase 3
- Positron Emission Mammography and Liquid Biopsy in Women With High-risk Breast ScreeningsRecruitingNCT06268405Not applicable
- Adding Adjuvant Cisplatin and Gemicitabine Versus Capecitabine in Triple-negative Breast Cancer Patients in Non pCR After Neoadjuvant Standard ChemotherapyNot yet recruitingNCT06268327Phase 2/3
- Feasibility of a Preoperative, Multimodal Lifestyle Intervention in Patients with BreastcancerRecruitingNCT06266312Not applicable
- ThermoBreast - Non-contact Breast Cancer Imaging Using AI-enhanced Thermography.RecruitingNCT06266026Not applicable
- Prevention of Postoperative Complications by Negative Pressure Therapy After Complex Breast Cancer SurgeryRecruitingNCT06265558Not applicable
- Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBCRecruitingNCT06263543Phase 2
- Transcriptional and Epimetabolic Profile of Breast Carcinoma With Luminal or HER2+ or Locally Advanced Triple-negative Histotype in Patients With/Without Previous Clinical History of Metabolic SyndromeRecruitingNCT06261918
- Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast CancerRecruitingNCT06260033Phase 2
- NEOadjuvant Abemaciclib and GIredestrant TriaL in Patients with ER-positive, HER2-negative Early Breast CancerRecruitingNCT06259929Phase 2
- Omission of Axillary Surgery in Breast Cancer PatientsRecruitingNCT06259513Not applicable
- LAG3 Expression in Triple Negative Breast CancerRecruitingNCT06259162Not applicable
- A Randomized Two-Arm Proof of Concept Study Testing A Novel Approach to Exercise Promotion Based on Affect-regulationRecruitingNCT06258993Not applicable
- Investigating the Effects of Different Incision Types on Aesthetic Outcomes and Incision-related Complications After Breast Reconstruction SurgeryEnrolling by invitationNCT06258863
- The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase II Clinical StudyRecruitingNCT06254690Phase 2
- Adebrelimab Combined With Fluzoparib in HRD-positive HR +/HER2- Advanced Breast CancerNot yet recruitingNCT06254066Phase 2
- A Phase 1/1b Study of IAM1363 in HER2 CancersRecruitingNCT06253871Phase 1
- TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast CancerRecruitingNCT06251544Phase 1
- Cardiac Rehabilitation for Breast Cancer SurvivorsRecruitingNCT06251401Not applicable
- Nurse-led Physical Activity Program Among Breast Cancer SurvivorsEnrolling by invitationNCT06248918Not applicable
- MRI Screening for Brain Metastases Among Patients With Triple Negative or HER2+ Stage II or III Breast CancerRecruitingNCT06247449Not applicable